当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › VIRCHOWS ARCHIV杂志
VIRCHOWS ARCHIV
基本信息
期刊名称 VIRCHOWS ARCHIV
VIRCHOWS ARCH
期刊ISSN 0945-6317
期刊官方网站 http://www.springer.com/medicine/pathology/journal/428
是否OA
出版商 Springer Verlag
出版周期 Monthly
始发年份 1994
年文章数 183
最新影响因子 3.5(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PATHOLOGY 病理学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.52 1.137 0.951
Medicine
Pathology and Forensic Medicine
40 / 184 78%
Biochemistry, Genetics and Molecular Biology
Cell Biology
153 / 265 42%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
204 / 375 45%
补充信息
自引率 4.80%
H-index 90
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
Submission to first decision
28 days
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0945-6317%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/viar
收稿范围

The Official Journal of the European Society of Pathology

Mission statement: To advance the scientific basis of human pathology by the publication (encouragement and dissemination) of high quality research (including molecular and translational studies) and thereby contribute to patient care.

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editor-in-Chief
Daniela Massi, Florence, Italy

Senior Editorial Consultant
Fred T. Bosman, Lausanne, Switzerland

Associate Editors 
Irene Esposito, Düsseldorf, Germany
Masashi Fukayama, Tokyo, Japan
Sigurd F. Lax, Graz, Austria 
Leticia Quintanilla-Martinez, Tübingen, Germany
Ales Ryska, Hradec Kralove, Czech Republic
Laura J. Tafe, Lebanon, NH, USA

Editorial Consultants Ex Officio ESP 
Pierre Bedossa, Paris, France
Ilmo Leivo, Helsinki, Finland
Marco Santucci, Florence, Italy

Past Editors
N. Volkan Adsay, Atlanta, GA, USA
Maria de Fátima Carneiro, Porto, Portugal
Manfred Dietel, Berlin, Germany
Vincenzo Eusebi, Bologna, Italy
Heinz Höfler, Munich, Germany
Günter Klöppel, Munich, Germany
Hans Kreipe, Hannover, Germany
Han van Krieken, Nijmegen, The Netherlands
Sunil Lakhani, Brisbane, Australia
Cord Langner, Graz, Austria 
Manuel Sobrinho-Simões, Porto, Portugal

Editorial Board
Abbas Agaimy, Erlangen, Germany
Kerstin Amann, Erlangen, Germany
Thomas Brenn, Edinburgh, United Kingdom
Reinhard Büttner, Bonn, Germany
John K.C. Chan, Hong Kong, SAR China
Beatrix Cochand-Priollet, Paris, France
Jane Dahlstrom, Adelaide, Australia
Ben Davidson, Oslo, Norway
Ronald de Krijger, Rotterdam, The Netherlands
Laurence de Leval, Lausanne, Switzerland
Michael den Bakker, Rotterdam, The Netherlands
Joachim Diebold, Lucerne, Switzerland
Arzu Ensari, Ankara, Turkey
Fabio Facchetti, Brescia, Italy
Falko Fend, Tübingen, Germany
Jean-Francois Flejou, Paris, France
Christopher Fletcher, Boston, MA, USA
Maria Pia Foschini, Bologna, Italy
Toru Furukawa, Sendai, Japan
Ondrej Hes, Plzen, Czech Republic
Jason L. Hornick, Boston, MA, USA
Shu Ichihara, Nagoya, Japan
Thomas Kirchner, Munich, Germany
David Klimstra, New York, NY, USA
Janina Kulka, Budapest, Hungary
Ryoji Kushima, Ōtsu, Japan
Alexander Lazar, Houston, TX, USA
Antonio Lopez-Beltran, Cordoba, Spain
Claudio Luchini, Verona, Italy
Rami Mahfouz, Beirut, Lebanon
Xavier Matias-Guiu, Barcelona, Spain
Thomas Mentzel, Friedrichshafen, Germany
Markku Miettinen, Bethesda, MD, USA
Holger Moch, Zürich, Switzerland
Rodolfo Montironi, Ancona, Italy
George Netto, Birmingham, AL, USA
Carlos Ortiz-Hidalgo, Mexico City, Mexico
Mauro Papotti, Turin, Italy
Giuseppe Pelosi, Milan, Italy
Aurel Perren, Bern, Switzerland
Guido Rindi, Rome, Italy
Christoph Röcken, Kiel, Germany
Andreas Rosenwald, Würzburg, Germany
Anna Sapino, Turin, Italy
Aldo Scarpa, Verona, Italy
Peter Schirmacher, Heidelberg, Germany
Tomas Slavik, Pretoria, South Africa
Kurt Werner Schmid, Essen, Germany
Fernando Schmitt, Porto, Portugal
Puay-Hoon Tan, Singapore
Tibor Tot, Falun, Sweden
Toyonori Tsuzuki, Nagakute, Japan
Marc van de Vijver, Amsterdam, The Netherlands
Zsuzsanna Varga, Zürich, Switzerland
Giuseppe Viale, Milan, Italy
Akihiko Yoshida, Tokyo, Japan
Giuseppe Zamboni, Verona, Italy
Nina Zidar, Ljubljana, Slovenia


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug